Jukka Perttu

Jukka Perttu is a journalist for Helsingin Sanomat in Finland. He is currently an Innovation Journalism Fellow at Stanford University and is working for Xconomy during his fellowship.

Recent posts

QinetiQ, Thermo Scientific Collaborate to Equip Explosive-Sniffing Robots with Smart Sensors
Chemically fueled improvised explosive devices (IEDs) are one of the deadliest hazards to soldiers in Iraq and Afghanistan, and incidents like the Oklahoma City bombing and the Sarin gas attack in... Read more »
MIT Spinoff Levant Power On Track to Produce Energy-Boosting Shock Absorbers For Cars, Tanks, and Trains
With gasoline prices on the rise and carbon dioxide emissions threatening to bring about global climate disaster, MIT spinoff startup Levant Power is trying to help drivers cut fuel consumption—by turning... Read more »
Pietzo’s Bikes Electrify Massachusetts Commuters
Millions of commuters suffer daily in traffic jams. Cars burn expensive, non-renewable gasoline and pollute our air while producing tons of carbon dioxide that threaten to bring about disastrous global climate... Read more »
QD Vision’s Quantum Dots Warm Up the Market for LED Lighting
Everyone knows that traditional incandescent lamps are inefficient and energy-wasting. But LEDs, one of the technologies vying to take their place, produce light that feels harsh and cold by comparison, leading... Read more »
Terrafugia Says Flying Car Likely to Take Off in Massachusetts, But Might Land Elsewhere
Terrafugia, the Woburn, MA-based company out to produce the first practical flying car—or street legal airplane, to use the company’s term— said today it plans to build its first commercial vehicle... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Webinar
Nov. 12 – High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocytes
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Eurofins DiscoverX

Sponsored · Whitepaper
IBM Watson Health Data in Action – Epidemiology Studies
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4

FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats

Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Jukka Perttu

Recent posts

QinetiQ, Thermo Scientific Collaborate to Equip Explosive-Sniffing Robots with Smart Sensors

MIT Spinoff Levant Power On Track to Produce Energy-Boosting Shock Absorbers For Cars, Tanks, and Trains

Pietzo’s Bikes Electrify Massachusetts Commuters

QD Vision’s Quantum Dots Warm Up the Market for LED Lighting

Terrafugia Says Flying Car Likely to Take Off in Massachusetts, But Might Land Elsewhere

Underwriters and Partners

What’s Next in Neuroscience Therapies

Nov. 12 – High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocytes

IBM Watson Health Data in Action – Epidemiology Studies

Xconomy on Demand

We offer a number of ways to subscribe for free!